Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Cash-and-Equivalents" stands at 301.65 Billion Japanese Yens as of 09/30/2025, the highest value since 09/30/2024.
As of the end of Eisai Co. Ltd.'s second quarter, the item "Cash and Equivalents" stands at 301.65 Billion JPY. This represents an increase of 5.70 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.30 percent compared to the value the year prior.
The 1 year change in percent is 12.30.
The 3 year change in percent is 14.03.
The 5 year change in percent is 32.29.
The 10 year change in percent is 88.39.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash and Equivalents | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash and Equivalents | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash and Equivalents | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash and Equivalents | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash and Equivalents | 280,205,508,085.11 |